Assessment of implementation of ferritin testing on donor return
Transfusion · 2026-07 · 66 (7) · 1358-1365
DOI: 10.1111/trf.70236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 21.04.2026. Verfasst von Mindy Goldman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Canadian Blood Services, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Ferritins, Blood Donors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
One mitigation strategy for donor iron deficiency is to implement ferritin testing and encourage donors with low ferritin to pause donation and increase iron intake. We evaluated positive outcomes (reduced hemoglobin deferrals) and negative outcomes (donor nonreturn) in a 2‐year observation period after implementing ferritin testing of female donors at each 10th donation.
Methods
Donors with ferritin below 25 ug/L were advised to pause donation for 6 months and see their health care practitioner about increasing iron intake but were not deferred. Ferritin results for donors screened in the first 6 months of the program (Jan–June 2023), hemoglobin on return and time to return in the 2 years following testing were calculated for low ferritin and normal/high ferritin donors.
Results
Twenty five percent of 8613 tested donors had low ferritin, associated with younger age, high donation frequency, and previous hemoglobin deferral. About one third of low ferritin donors returned to donate less than 6 months after testing, and had a hemoglobin deferral rate of 16%, compared to 4.4% in those who waited 6 months or more and 5.2% in donors with normal ferritin. After 2 years, 77.5% of low ferritin compared to 88.5% of normal/high ferritin donors returned to donate.
Conclusion
Iron deficiency was common. Low ferritin donors who paused donation and returned to donate had hemoglobin deferral rates similar to normal ferritin donors. However, many returned early and had high failure rates. Two years after testing, an 11% difference in return rates remained between low and normal/high ferritin donors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Canadian Blood Services, Ottawa, Ontario, Canada.
- Department of Pathology & Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Canadian Blood Services, University of Toronto, Toronto, Ontario, Canada.
- Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Mindy Goldman, Chinchin Wang, Aditi Khandelwal, Sheila F O'Brien
Zitieren
APA
Goldman, M., Wang, C., Khandelwal, A., & O'Brien, S. F. (2026). Assessment of implementation of ferritin testing on donor return. Transfusion, 66(7), 1358-1365. https://doi.org/10.1111/trf.70236
Vancouver
Goldman M, Wang C, Khandelwal A, O'Brien SF. Assessment of implementation of ferritin testing on donor return. Transfusion. 2026;66(7):1358-1365. doi:10.1111/trf.70236
BibTeX
@article{Goldman2026,
author = {Goldman, Mindy and Wang, Chinchin and Khandelwal, Aditi and O'Brien, Sheila F},
title = {Assessment of implementation of ferritin testing on donor return},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {7},
pages = {1358--1365},
doi = {10.1111/trf.70236}
}
EUVIMED